affiliation not provided to SSRN
locally advanced, Non-small cell lung cancer (NSCLC), older patients, chemoradiotherapy, daily low-dose carboplatin, carboplatin plus nab-paclitaxel
Non-small cell lung cancer, Interstitial lung disease, Carboplatin, Paclitaxel, Nab-paclitaxel, Rechallenge